By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Maximum likelihood multi-user MIMO detection with blind modulation classification

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Biology - Today’s Cell Biology Science Briefing | April 23rd 2026, 9:00:12 am

Biology

Today’s Cell Biology Science Briefing | April 23rd 2026, 9:00:12 am

Last updated: April 23, 2026 7:14 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
Scientists have discovered that a new type of drug can block the growth and blood vessel formation of several cancers by targeting two key proteins, HIF-1 and HIF-2, which tumors use to survive and spread. This dual-action drug was more effective than existing treatments and even helped overcome resistance to common immunotherapies in over half of the cases studied.
Source →

•
A new study reveals that the transition from a benign growth to aggressive pancreatic cancer is driven by a self-reinforcing “niche” created by opposing forces within the tumor. Disrupting the activity of key cancer genes like p53 or KRAS can collapse this niche and stop the cancer from becoming malignant.
Source →

•
Researchers found that the movement of molecules inside a cell is best described by a “porous media” framework, a model that applies not just to simple molecules but also to more complex biological ones. This challenges previous assumptions and provides a more accurate way to understand how substances travel and function within our cells.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Neurology Science Briefing | April 23rd 2026, 9:00:12 am
Next Article Today’s Public Health Science Briefing | April 23rd 2026, 9:00:12 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

A fatal side-effect of cancer immunotherapy is pinned to a specific inflammatory circuit

This week’s Biology Key Highlights

Today’s Cell Biology Science Briefing | March 25th 2026, 1:00:12 pm

The birth of genes from scratch

Science Briefing

Today’s Immunology Science Briefing | March 19th 2026, 1:00:12 pm

Science Briefing

A new computational tool maps genetic traits across the tree of life

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?